HomeCompareLHDX vs EPRT

LHDX vs EPRT: Dividend Comparison 2026

LHDX yields 442.18% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LHDX wins by $24061.25M in total portfolio value
10 years
LHDX
LHDX
● Live price
442.18%
Share price
$0.45
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24061.31M
Annual income
$16,652,908,317.91
Full LHDX calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — LHDX vs EPRT

📍 LHDX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLHDXEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LHDX + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LHDX pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LHDX
Annual income on $10K today (after 15% tax)
$37,585.67/yr
After 10yr DRIP, annual income (after tax)
$14,154,972,070.22/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, LHDX beats the other by $14,154,961,155.60/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LHDX + EPRT for your $10,000?

LHDX: 50%EPRT: 50%
100% EPRT50/50100% LHDX
Portfolio after 10yr
$12030.69M
Annual income
$8,326,460,579.31/yr
Blended yield
69.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

LHDX
Analyst Ratings
1
Hold
1
Sell
Consensus: Hold
Altman Z
-3.0
Piotroski
2/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LHDX buys
0
EPRT buys
0
No recent congressional trades found for LHDX or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLHDXEPRT
Forward yield442.18%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$24061.31M$63.4K
Annual income after 10y$16,652,908,317.91$12,840.73
Total dividends collected$23397.53M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy

Year-by-year: LHDX vs EPRT ($10,000, DRIP)

YearLHDX PortfolioLHDX Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$54,918$44,218.44$11,205$505.18+$43.7KLHDX
2$285,717$226,953.99$12,672$682.46+$273.0KLHDX
3$1,409,215$1,103,497.88$14,490$930.48+$1.39MLHDX
4$6,594,479$5,086,619.59$16,786$1,282.69+$6.58MLHDX
5$29,301,933$22,245,840.16$19,753$1,791.56+$29.28MLHDX
6$123,733,671$92,380,602.86$23,677$2,541.64+$123.71MLHDX
7$496,971,503$364,576,474.39$29,008$3,672.99+$496.94MLHDX
8$1,900,271,005$1,368,511,496.83$36,463$5,425.08+$1900.23MLHDX
9$6,923,738,907$4,890,448,931.51$47,238$8,221.57+$6923.69MLHDX
10$24,061,308,948$16,652,908,317.91$63,385$12,840.73+$24061.25MLHDX

LHDX vs EPRT: Complete Analysis 2026

LHDXStock

Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California.

Full LHDX Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this LHDX vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LHDX vs SCHDLHDX vs JEPILHDX vs OLHDX vs KOLHDX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.